Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Jazz Pharmaceuticals
Baylor College of Medicine
Avacta Life Sciences Ltd
University of Nebraska
Bayer
LigaChem Biosciences, Inc.
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Universitair Ziekenhuis Brussel
Hoffmann-La Roche
Stanford University
Klus Pharma Inc.
Eastern Cooperative Oncology Group
Xencor, Inc.
MacroGenics
AIDS Malignancy Consortium
Stanford University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University Health Network, Toronto
Alliance for Clinical Trials in Oncology
SWOG Cancer Research Network
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
OHSU Knight Cancer Institute
University of Arizona
Otsuka Novel Products GmbH
Duke University
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
East and North Hertfordshire NHS Trust
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
National Institutes of Health Clinical Center (CC)
NYU Langone Health
Case Comprehensive Cancer Center